EMEDOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Electromedical Technologies, Inc
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.00+0.00 (+9900.00%)
Close on Oct 19, 2026
- Market cap
- $68.10K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
$0.0000 (0.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
Electromedical Technologies, Inc saw revenue fall 35.1% to $922.01K over the twelve months to Sep 30, 2024. Free cash flow was -$1.57M.
Revenue
$922.01K
-35.1% vs. a year earlier
Operating income
-$1.01M
TTM Q3 2024
Free cash flow
-$1.57M
FY2023
EPS, diluted
-$0.00
TTM Q3 2024
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2024
Valuation
- Market cap
- $68.10K
- P/E ratio
- –
- Price to sales
- 0.07
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -2301.17%
Fundamentals
- Revenue
- $922.01K
- Net income
- -$1.68M
- EPS, diluted
- -$0.00
- Free cash flow
- -$1.57M
- Book value per share
- -$0.01
- Diluted shares
- 681M
Six years at a glance
Fiscal years 2018 to 2023 and trailing twelve months, USD
Revenue
$922.01K-35.1% YoY
Gross profit
$692.23K-37.5% YoY
Operating income
-$1.01M
Net income
-$1.68M
EPS, diluted
-$0.00
Free cash flow
–
Reported periodTrailing twelve months